TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
GlaxoSmithKline AS
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
598,778
|
602,606
|
583,188 |
| Financial expenses |
587
|
214
|
1,792 |
| Earnings before taxes |
18,425
|
19,744
|
21,730 |
| Total assets |
193,617
|
192,246
|
254,629 |
| Current assets |
139,465
|
137,979
|
195,171 |
| Current liabilities |
116,515
|
110,096
|
168,288 |
| Equity capital |
77,102
|
82,150
|
86,340 |
| - share capital |
630
|
671
|
708 |
| Employees (average) | 56 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
39.8%
|
42.7%
|
33.9% |
| Turnover per employee | 10,414 | ||
| Profit as a percentage of turnover |
3.1%
|
3.3%
|
3.7% |
| Return on assets (ROA) |
9.8%
|
10.4%
|
9.2% |
| Current ratio |
119.7%
|
125.3%
|
116.0% |
| Return on equity (ROE) |
23.9%
|
24.0%
|
25.2% |
| Change turnover |
33,200
|
50,051
|
-69,660 |
| Change turnover % |
6%
|
9%
|
-11% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.